We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$817M
AUM Growth
-$36.2M
Cap. Flow
-$39.4M
Cap. Flow %
-4.82%
Top 10 Hldgs %
12.04%
Holding
1,060
New
418
Increased
118
Reduced
111
Closed
413

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$12.8M
2
CRM icon
Salesforce
CRM
+$9.18M
3
NKE icon
Nike
NKE
+$8.85M
4
DHR icon
Danaher
DHR
+$8.43M
5
AMZN icon
Amazon
AMZN
+$8.08M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$17.9M
2
TSLA icon
Tesla
TSLA
+$16.6M
3
CVX icon
Chevron
CVX
+$15.3M
4
MDB icon
MongoDB
MDB
+$9.4M
5
FTNT icon
Fortinet
FTNT
+$8.82M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Consumer Discretionary 15.97%
3 Healthcare 14.57%
4 Industrials 11.33%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLX icon
726
Clorox
CLX
$12.6B
-26,400
Closed -$4.3M
GPGI
727
GPGI Inc
GPGI
$3.87B
-29,968
Closed -$349K
CMS icon
728
CMS Energy
CMS
$21.5B
-51,700
Closed -$3.65M
COLB icon
729
Columbia Banking Systems
COLB
$8.57B
-12,599
Closed -$329K
COLL icon
730
Collegium Pharmaceutical
COLL
$812M
-8,391
Closed -$324K
COO icon
731
Cooper Companies
COO
$13.8B
-22,981
Closed -$2.54M
COR icon
732
Cencora
COR
$61.4B
-13,392
Closed -$3.01M
COUR icon
733
Coursera
COUR
$1.72B
-44,158
Closed -$351K
CPRX
734
DELISTED
Catalyst Pharmaceutical
CPRX
-14,741
Closed -$293K
CPT icon
735
Camden Property Trust
CPT
$12.3B
-6,406
Closed -$791K
CRBU icon
736
Caribou Biosciences
CRBU
$173M
-26,084
Closed -$51.1K
CRC icon
737
California Resources
CRC
$4.65B
-8,500
Closed -$446K
CRI icon
738
Carter's
CRI
$1.24B
-20,300
Closed -$1.32M
CRS icon
739
Carpenter Technology
CRS
$23.9B
-2,600
Closed -$415K
CRSP icon
740
CRISPR Therapeutics
CRSP
$5.58B
-8,800
Closed -$413K
CRTO icon
741
Criteo S.A.
CRTO
$845M
-5,142
Closed -$207K
CSGS
742
DELISTED
CSG Systems International
CSGS
-6,243
Closed -$304K
CUZ icon
743
Cousins Properties
CUZ
$4.85B
-26,887
Closed -$793K
CVS icon
744
CVS Health
CVS
$120B
-61,100
Closed -$3.84M
CXAI icon
745
CXApp
CXAI
$8.77M
-232
Closed -$19.5K
CXM icon
746
Sprinklr
CXM
$1.89B
-86,650
Closed -$670K
CYBR
747
DELISTED
CyberArk
CYBR
-6,428
Closed -$1.87M
DAL icon
748
Delta Air Lines
DAL
$53.3B
-58,400
Closed -$2.97M
DAN icon
749
Dana Inc
DAN
$3.27B
-18,200
Closed -$192K
DAVA icon
750
Endava
DAVA
$176M
-25,629
Closed -$655K

Similar funds

Bayesian Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Bayesian Capital Management held 1,060 positions worth $817M, down 4.2% from $853M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $39.4M in Q4 2024, closing 413 positions and reducing 111 holdings. Its most notable exit was Netflix, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Amgen worth $11.2M.

  • Bayesian Capital Management's largest Q4 2024 buy was Amgen: 43,000 shares worth $11.2M.
  • Bayesian Capital Management added most to Nike in Q4 2024, an estimated $8.85M increase.
  • Bayesian Capital Management's biggest Q4 2024 reduction was Tesla, cutting an estimated $16.6M.
  • Bayesian Capital Management fully exited Netflix in Q4 2024, selling an estimated $17.9M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $817M portfolio in Q4 2024.
  • Bayesian Capital Management opened 418 new positions and closed 413 in Q4 2024.
  • Bayesian Capital Management's portfolio value fell 4.2% quarter-over-quarter to $817M.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.